RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 16 - per page Next page
Order by
Novel anti-inflammatory omega-3 fatty acids sourced from green lipped mussels.
The omega-3 fatty acids are extracted from New Zealand green lipped mussels and developed into oils for use in anti-inflammatory compounds by our UK based clients. More
Product enhancement of small and large molecules in a range of dosage forms
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms. More
Optimised pulmonary and nasal therapies using supercritical fluid (SCF) particle engineering
Supercritical fluid crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
Tackling challenges of poor solubility
Enhancing the dissolution performance of small and large molecules in a range of dosage forms More
Stabilisation and rapid reconstitution of biopharmaceuticals
Improving the reconstitution and increasing the stability of biomolecules using supercritical fluid (SCF) processing More
Protein Arginine N-methyltransferase 2 (PRMT-2), a Modulator of NF-kappaB, E2F1, and STAT3 Activity
Methods of modulating PRMT-2 activity or expression in cells More
Novel Glycated Peptides and Proteins as Biomarkers for Diabetes Control
Novel glycated peptide and protein biomarkers for glycemic control, as well as a method to monitor glycemic control in diabetic patients More
Composition for glucose sensing comprising of nanofibrous membrane and method for manufacturing non-enzymatic glucose biosensor using the same
Diabetes mellitus, a metabolic disease caused by deficiency of insulin, displays a higher or lower level of glucose concentration in blood than normal range(80-120mg/dL). More
Maternal Multi-Nutrient Against Diabetes-Related Birth Defects (03-29)
Nutritional intervention to abrogate the adverse effects in diabetes-related pregnancy More
Methods for Accurately Measuring and Regulating Bound Adrenomedullin
The technology provides methods for diagnosis and treatment of conditions such as cancer, diabetes, or other conditions that are influenced by AM levels. More
Displaying 1..10 of 16 - per page Next page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Diabetes Drug Discoveries 2009: what the future holds
Feb 2009 - 160 pages - $1,390
Epidemiology: Diabetes in India - a country faced with a mammoth diabetes epidemic
Mar 2011 - 43 pages - $5,700
Epidemiology: Diabetes in Australia - Despite government efforts to promote healthy lifestyles, the number of cases of diabetes in Australia is set to soar
Jun 2011 - 44 pages - $5,700
Epidemiology: Type 1 diabetes - There will be an increasing number of new cases of type 1 diabetes in the seven major markets in the coming decade
Dec 2010 - 25 pages - $5,700
Epidemiology: Diabetes in China - Aging population, rising overweight and obesity are driving the diabetes epidemic
Mar 2011 - 42 pages - $5,700
Hot Topics in Type 2 Diabetes: Complications and Comorbidities – Physician insight on diabetic complications, comorbidities and treatment
Aug 2011 - 55 pages - $5,700
Epidemiology: Type 2 Diabetes
Dec 2010 - 31 pages - $5,700
Treatment Algorithms: Type 2 Diabetes – Novel classes drive fragmentation of treatment choices in type 2 diabetes
Jul 2011 - 92 pages - $7,600
Tradjenta (linagliptin) - First Member of DPP - 4 Inhibitor Class to Be Approved by US FDA at One Dosage Strength
May 2011 - 7 pages - $500
Byetta Wave 4 Tracking Survey; Trends in Usage of Type II Diabetes Mellitus Therapeutics
Nov 2007 - $2,500
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us